• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Lorelei A. Mucci, MPH, ScD


  • Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA.SPINK1 Protein Expression and Prostate Cancer Progression.Clin Cancer Res. 2014 Mar 31.
  • Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, Loda M, Giovannucci E, Mucci LA, Olumi AF.5α-reductase inhibitors and risk of high-grade or lethal prostate cancer.JAMA Intern Med. 2014 Aug 1(8):1301-7.
  • Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA.Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG positive prostate cancer.Cancer Epidemiol Biomarkers Prev. 2014 Jun 12.
  • Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA.Genetic variation across C-reactive protein and risk of prostate cancer.Prostate. 2014 Jul;74(10):1034-42.
  • Preston MA, Riis AH, Ehrenstein V, Breau RH, Batista JL, Olumi AF, Mucci LA, Adami HO, Sørensen HT.Metformin Use and Prostate Cancer Risk.Eur Urol. 2014 May 21.
  • Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, Pukkala E, Christensen K, Adami HO, Holm NV, Nuttall E, Hansen S, Hartman M, Czene K, Harris JR, Kaprio J, Mucci LA.The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer.Cancer Epidemiol Biomarkers Prev. 2014 May 8.
  • Shui IM, Lindström S, Kibel AS, Berndt SI, Campa D, Gerke T, Penney KL, Albanes D, Berg C, Bueno-de-Mesquita HB, Chanock S, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giles GG, Henderson B, Hoover R, Johansson M, Le Marchand L, Ma J, Navarro C, Overvad K, Schumacher FR, Severi G, Siddiq A, Stampfer M, Stevens VL, Travis RC, Trichopoulos D, Vineis P, Mucci LA, Yeager M, Giovannucci E, Kraft P.Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Eur Urol. 2014 Jun;65(6):1069-75.
  • Torfadottir JE, Stampfer MJ, Mucci LA, Giovannucci EL.RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.Journal of the National Cancer Institute. 2014 Apr;106(4):dju018.
  • Bismar TA, Alshalalfa M, Petersen LF, Teng LH, Gerke T, Bakkar A, Al-Mami A, Liu S, Dolph M, Mucci LA, Alhajj R.Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome.BJU Int. 2014 Feb;113(2):309-19.
  • Alemozaffar M, Sanda M, Yecies D, Mucci LA, Stampfer MJ, Kenfield SA.Benchmarks for Operative Outcomes of Robotic and Open Radical Prostatectomy: Results from the Health Professionals Follow-up Study.Eur Urol. 2014 Feb 11.
  • Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, Giovannucci E.Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.Journal of the National Cancer Institute. 2014 Feb;106(2):djt430.
  • Mucci LA, Stampfer MJ.Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer.J Clin Oncol. 2014 Jan 1;32(1):1-2.
  • Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kantoff PW, Giovannucci EL, Loda M, Mucci LA.Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.Journal of the National Cancer Institute. 2013 Dec 18;105(24):1881-90.
  • Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA.Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer.Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2354-63.
  • Möller E, Adami HO, Mucci LA, Lundholm C, Bellocco R, Johansson JE, Grönberg H, Bälter K.Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden.Cancer Causes Control. 2013 Dec;24(12):2143-55.
  • Zu K, Martin NE, Fiorentino M, Flavin R, Lis RT, Sinnott JA, Finn S, Penney KL, Ma J, Fazli L, Gleave ME, Bismar TA, Stampfer MJ, Pollak MN, Loda M, Mucci LA, Giovannucci E.Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1984-93.
  • Hogervorst JG, Fortner RT, Mucci LA, Tworoger SS, Eliassen AH, Hankinson SE, Wilson KM.Associations between dietary acrylamide intake and plasma sex hormone levels.Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2024-36.
  • Sharma J, Gray KP, Evan C, Nakabayashi M, Fichorova R, Rider J, Mucci L, Kantoff PW, Sweeney CJ.Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival.Prostate. 2013 Oct 16.
  • Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK.Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.Cancer Discovery. 2013 Oct;3(10):1130-41.
  • Russnes KM, Wilson KM, Epstein MM, Kasperzyk JL, Stampfer MJ, Kenfield SA, Smeland S, Blomhoff R, Giovannucci EL, Willett WC, Mucci LA.Total antioxidant intake in relation to prostate cancer incidence in the health professionals follow up study.Int J Cancer. 2013 Aug 19.
  • Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, Finn S, Giovannucci E, Sesso HD, Loda M, Mucci LA, Fiorentino M.Gleason grade progression is uncommon.Cancer Res. 2013 Aug 15;73(16):5163-8.
  • Wilson KM, Bälter K, Möller E, Adami HO, Andrén O, Andersson SO, Grönberg H, Mucci LA.Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study.Cancer Causes Control. 2013 Aug;24(8):1575-81.
  • Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA.Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.Ann Oncol. 2013 Jun;24(6):1427-34.
  • Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, Czeisler CA, Launer L, Harris T, Stampfer MJ, Gudnason V, Lockley SW.Sleep disruption among older men and risk of prostate cancer.Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):872-9.
  • Torfadottir JE, Valdimarsdottir UA, Mucci LA, Kasperzyk JL, Fall K, Tryggvadottir L, Aspelund T, Olafsson O, Harris TB, Jonsson E, Tulinius H, Gudnason V, Adami HO, Stampfer M, Steingrimsdottir L.Consumption of Fish Products across the Lifespan and Prostate Cancer Risk.PLoS ONE. 2013;8(4):e59799.
  • Gershman B, Shui IM, Mucci LA.Reply from Authors re: Andrea Salonia. Androgens and Prostate Cancer: We Are Still (Almost) Completely Ignorant. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.02.041: Androgens and Prostate Cancer: Clinical Implications and Future Directions.Eur Urol. 2013 Mar 19.
  • Baena E, Shao Z, Linn DE, Glass K, Hamblen MJ, Fujiwara Y, Kim J, Nguyen M, Zhang X, Godinho FJ, Bronson RT, Mucci LA, Loda M, Yuan GC, Orkin SH, Li Z.ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.Genes Dev. 2013 Mar 15;27(6):683-98.
  • Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA.A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.Clin Cancer Res. 2013 Mar 15;19(6):1612-9.
  • Gershman B, Shui IM, Stampfer M, Platz EA, Gann PH, Sesso HL, Dupre N, Giovannucci E, Mucci LA.Prediagnostic Circulating Sex Hormones Are Not Associated with Mortality for Men with Prostate Cancer.Eur Urol. 2013 Jan 11.
  • Song Y, Chavarro JE, Cao Y, Qiu W, Mucci L, Sesso HD, Stampfer MJ, Giovannucci E, Pollak M, Liu S, Ma J.Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians.J Nutr. 2013 Feb;143(2):189-96.
  • Penney KL, Li H, Mucci LA, Loda M, Sesso HD, Stampfer MJ, Ma J.Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.Prostate. 2012 Nov 5.
  • Shui IM, Mucci LA, Wilson KM, Kraft P, Penney KL, Stampfer MJ, Giovannucci E.Common genetic variation of the calcium sensing receptor and lethal prostate cancer risk.Cancer Epidemiol Biomarkers Prev. 2012 Nov 2.
  • Epstein MM, Edgren G, Rider JR, Mucci LA, Adami HO.Temporal trends in cause of death among Swedish and US men with prostate cancer.Journal of the National Cancer Institute. 2012 Sep 5;104(17):1335-42.
  • Etzioni R, Mucci LA, Chen S, Johansson JE, Fall K, Adami HO.Increasing use of radical prostatectomy for non-lethal prostate cancer in Sweden.Clin Cancer Res. 2012 Aug 27.
  • Epstein MM, Kasperzyk JL, Mucci LA, Giovannucci E, Price A, Wolk A, Håkansson N, Fall K, Andersson SO, Andrén O.Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.Am J Epidemiol. 2012 Aug 1;176(3):240-52.
  • Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, Mucci LA.Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies.Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1002-11.
  • Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA.Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.Cancer Causes Control. 2012 Aug;23(8):1359-66.
  • Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon A, Suppan C, Flavin R, Sesso H, Rider JR, Sweeney CS, Stampfer MJ, Fiorentino M, Kantoff PW, Sanda MG, Giovannucci E, Ding EL, Loda M, Mucci LA.The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: a Cohort Study and Meta-analysis.Cancer Epidemiol Biomarkers Prev. 2012 Jun 26.
  • Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, Niu Y, Cheong JK, Hunter DJ, Stampfer MJ, Hsu SI.Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.Carcinogenesis. 2011 Mar 18.
  • Epstein MM, Kasperzyk JL, Andrén O, Giovannucci EL, Wolk A, Håkansson N, Andersson SO, Johansson JE, Fall K, Mucci LA.Dietary zinc and prostate cancer survival in a Swedish cohort.Am J Clin Nutr. 2011 Mar;93(3):586-93.
  • Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Labrot ES, Wu X, Lis R, Hoshida Y, Hiller D, Hu B, Jiang S, Zheng H, Stegh AH, Scott KL, Signoretti S, Bardeesy N, Wang YA, Hill DE, Golub TR, Stampfer MJ, Wong WH, Loda M, Mucci L, Chin L, DePinho RA.SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.Nature. 2011 Feb 10;470(7333):269-73.
  • Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, Oh WK, Kantoff PW, Hahn WC, Freedman ML.Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.PLoS Genet. 2010;6(11):e1001204.
  • Penney KL, Pyne S, Schumacher FR, Sinnott JA, Mucci LA, Kraft PL, Ma J, Oh WK, Kurth T, Kantoff PW, Giovannucci EL, Stampfer MJ, Hunter DJ, Freedman ML.Genome-Wide Association Study of Prostate Cancer Mortality.Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2869-76.
  • Szymanski KM, Wheeler DC, Mucci LA.Fish consumption and prostate cancer risk: a review and meta-analysis.Am J Clin Nutr. 2010 Nov;92(5):1223-33.
  • Wilson KM, Mucci LA, Rosner BA, Willett WC.A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers.Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2503-15.
  • Meyer MS, Mucci LA, Andersson SO, Andrén O, Johansson JE, Tretli S, Adami HO.Homogeneous prostate cancer mortality in the Nordic countries over four decades.Eur Urol. 2010 Sep;58(3):427-32.
  • Meyer MS, Penney KL, Stark JR, Schumacher FR, Sesso HD, Loda M, Fiorentino M, Finn S, Flavin RJ, Kurth T, Price AL, Giovannucci EL, Fall K, Stampfer MJ, Ma J, Mucci LA.Genetic variation in RNASEL associated with prostate cancer risk and progression.Carcinogenesis. 2010 Sep;31(9):1597-603.
  • Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M.Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival.J Clin Oncol. 2010 Sep 1;28(25):3958-64.
  • Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T, Mucci LA, Hunter DJ, Kantoff PW, Stampfer MJ, Ma J.A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.Cancer Prev Res (Phila Pa). 2010 May;3(5):604-10.
  • Fiorentino M, Judson G, Penney K, Flavin R, Stark J, Fiore C, Fall K, Martin N, Ma J, Sinnott J, Giovannucci E, Stampfer M, Sesso HD, Kantoff PW, Finn S, Loda M, Mucci L.Immunohistochemical expression of BRCA1 and lethal prostate cancer.Cancer Res. 2010 Apr 15;70(8):3136-9.
  • Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y, Perner S, Adami HO, Fall K, Mucci LA, Kantoff PW, Stampfer M, Andersson SO, Varenhorst E, Johansson JE, Gerstein MB, Golub TR, Rubin MA, Andren O.Molecular sampling of prostate cancer: a dilemma for predicting disease progression.BMC Med Genomics. 2010 Mar 16;3(1):8.
  • Fang F, Keating NL, Mucci LA, Adami HO, Stampfer MJ, Valdimarsdóttir U, Fall K.Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States.Journal of the National Cancer Institute. 2010 Mar 3;102(5):307-14.
  • Vikström AC, Wilson KM, Paulsson B, Athanassiadis I, Grönberg H, Adami HO, Adolfsson J, Mucci LA, Bälter K, Törnqvist M.Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobin-adducts and questionnaire data.Food Chem Toxicol. 2010 Mar;48(3):820-4.
  • Mucci LA, Stark JR, Pollak MN, Li H, Kurth T, Stampfer MJ, Ma J.Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study.Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):484-91.
  • Arora M, Weuve J, Fall K, Pedersen NL, Mucci LA.An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study.Am J Epidemiol. 2010 Jan 15;171(2):253-9.
  • Li H, Stampfer MJ, Mucci L, Rifai N, Qiu W, Kurth T, Ma J.A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.Clin Chem. 2010 Jan;56(1):34-43.
  • Fall K, Fang F, Mucci LA, Ye W, Andrén O, Johansson JE, Andersson SO, Sparén P, Klein G, Stampfer M, Adami HO, Valdimarsdóttir U.Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study.PLoS Med. 2009 Dec;6(12):e1000197.
  • Mucci LA, Powolny A, Giovannucci E, Liao Z, Kenfield SA, Shen R, Stampfer MJ, Clinton SK.Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study.J Clin Oncol. 2009 Nov 20;27(33):5627-33.
  • Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA.Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study.Journal of the National Cancer Institute. 2009 Oct 21;101(20):1406-11.
  • Stark JR, Mucci L, Rothman KJ, Adami HO.Screening for prostate cancer remains controversial.BMJ. 2009;339:b3601.
  • Kasperzyk JL, Fall K, Mucci LA, Håkansson N, Wolk A, Johansson JE, Andersson SO, Andrén O.One-carbon metabolism-related nutrients and prostate cancer survival.Am J Clin Nutr. 2009 Sep;90(3):561-9.
  • Mucci LA,Stark JR,Figg WD,Schumacher F,Li H,Abe M,Hennessy K,Stampfer MJ,Gaziano JM,Ma J,Kantoff PW.Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study.Int J Cancer. 2009 Sep 1;125(5):1143-6.
  • Stark JR,Perner S,Stampfer MJ,Sinnott JA,Finn S,Eisenstein AS,Ma J,Fiorentino M,Kurth T,Loda M,Giovannucci EL,Rubin MA,Mucci LA.Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?.J Clin Oncol. 2009 Jul 20;27(21):3459-64.
  • Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer MJ, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML.Evaluation of the 8q24 prostate cancer risk locus and MYC expression.Cancer Res. 2009 Jul 1;69(13):5568-74.
  • Stark JR, Wiklund F, Grönberg H, Schumacher F, Sinnott JA, Stampfer MJ, Mucci LA, Kraft P.Toll-like receptor signaling pathway variants and prostate cancer mortality.Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1859-63.
  • Mucci LA,Adami HO.The plight of the potato: is dietary acrylamide a risk factor for human cancer?.Journal of the National Cancer Institute. 2009 May 6;101(9):618-21.
  • Penney KL,Salinas CA,Pomerantz M,Schumacher FR,Beckwith CA,Lee GS,Oh WK,Sartor O,Ostrander EA,Kurth T,Ma J,Mucci L,Stanford JL,Kantoff PW,Hunter DJ,Stampfer MJ,Freedman ML.Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.Clin Cancer Res. 2009 May 1;15(9):3223-30.
  • Migita T,Ruiz S,Fornari A,Fiorentino M,Priolo C,Zadra G,Inazuka F,Grisanzio C,Palescandolo E,Shin E,Fiore C,Xie W,Kung AL,Febbo PG,Subramanian A,Mucci L,Ma J,Signoretti S,Stampfer M,Hahn WC,Finn S,Loda M.Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.Journal of the National Cancer Institute. 2009 Apr 1;101(7):519-32.
  • Wilson KM,Mucci LA,Cho E,Hunter DJ,Chen WY,Willett WC.Dietary acrylamide intake and risk of premenopausal breast cancer.Am J Epidemiol. 2009 Apr 15;169(8):954-61.
  • Stark JR,Li H,Kraft P,Kurth T,Giovannucci EL,Stampfer MJ,Ma J,Mucci LA.Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.Int J Cancer. 2009 Jun 1;124(11):2683-9.
  • Dhillon PK,Barry M,Stampfer MJ,Perner S,Fiorentino M,Fornari A,Ma J,Fleet J,Kurth T,Rubin MA,Mucci LA.Aberrant cytoplasmic expression of p63 and prostate cancer mortality.Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):595-600.
  • Wilson KM,Balter K,Adami HO,Gronberg H,Vikstrom AC,Paulsson B,Tornqvist M,Mucci LA.Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study.Int J Cancer. 2009 May 15;124(10):2384-90.
  • Kakizoe T,Mucci LA,Albertsen PC,Droller MJ.Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.Scand J Urol Nephrol Suppl. 2008 Sep(218):191-212. Review.
  • Fiorentino M,Zadra G,Palescandolo E,Fedele G,Bailey D,Fiore C,Nguyen PL,Migita T,Zamponi R,Di Vizio D,Priolo C,Sharma C,Xie W,Hemler ME,Mucci L,Giovannucci E,Finn S,Loda M.Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer.Lab Invest. 2008 Dec;88(12):1340-8.
  • Ma J,Li H,Giovannucci E,Mucci L,Qiu W,Nguyen PL,Gaziano JM,Pollak M,Stampfer MJ.Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.Lancet Oncol. 2008 Nov;9(11):1039-47.
  • Cnattingius S,Eloranta S,Adami HO,Axelsson O,Dickman PW,Hsieh CC,Mucci LA,Trichopoulos D,Lambe M,Johansson AL.Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset.Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2344-9.
  • Mucci LA,Wilson KM.Acrylamide intake through diet and human cancer risk.J Agric Food Chem. 2008 Aug 13;56(15):6013-9.
  • Mucci LA,Pawitan Y,Demichelis F,Fall K,Stark JR,Adami HO,Andersson SO,Andren O,Eisenstein A,Holmberg L,Huang W,Kantoff PW,Kim R,Perner S,Stampfer MJ,Johansson JE,Rubin MA.Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1682-8.
  • Baik I,Lambe M,Liu Q,Chie L,Cnattingius S,Mucci LA,Riman T,Ekbom A,Adami HO,Hsieh CC.Birth spacing and maternal risk of invasive epithelial ovarian cancer in a Swedish nationwide cohort.Cancer Causes Control. 2008 Dec;19(10):1131-7.
  • Setlur SR,Mertz KD,Hoshida Y,Demichelis F,Lupien M,Perner S,Sboner A,Pawitan Y,Andren O,Johnson LA,Tang J,Adami HO,Calza S,Chinnaiyan AM,Rhodes D,Tomlins S,Fall K,Mucci LA,Kantoff PW,Stampfer MJ,Andersson SO,Varenhorst E,Johansson JE,Brown M,Golub TR,Rubin MA.Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.Journal of the National Cancer Institute. 2008 Jun 4;100(11):815-25.
  • Mucci LA,Spiegelman D.Vitamin D and prostate cancer risk--a less sunny outlook?.Journal of the National Cancer Institute. 2008 Jun 4;100(11):759-61. Review.
  • Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrn O, Eisenstein AS, Holmberg L, Huang W, Kantoff PW, Perner S, Stampfer MJ, Johansson JE, Rubin MA.Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort.Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):249-51.
  • Baik I, Lambe M, Liu Q, Cnattingius S, Mucci LA, Riman T, Ekbom A, Adami HO, Hsieh CC.Gender of offspring and maternal risk of invasive epithelial ovarian cancer.Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2314-20.
  • McIntyre MH, Kantoff PW, Stampfer MJ, Mucci LA, Parslow D, Li H, Gaziano JM, Abe M, Ma J.Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms.Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2233-6.
  • Bakaysa SL, Mucci LA, Slagboom PE, Boomsma DI, McClearn GE, Johansson B, Pedersen NL.Telomere length predicts survival independent of genetic influences.Aging Cell. 2007 Dec;6(6):769-74.
  • Mucci LA, Dickman PW, Lambe M, Adami HO, Trichopoulos D, Riman T, Hsieh CC, Cnattingius S.Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort.Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1828-32.
  • Andrn O, Fall K, Andersson SO, Rubin MA, Bismar TA, Karlsson M, Johansson JE, Mucci LA.MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden.Br J Cancer. 2007 Sep 17;97(6):730-4.
  • Demichelis F, Fall K, Perner S, Andrn O, Schmidt F, Setlur SR, Hoshida Y, Mosquera JM, Pawitan Y, Lee C, Adami HO, Mucci LA, Kantoff PW, Andersson SO, Chinnaiyan AM, Johansson JE, Rubin MA.TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.Oncogene. 2007 Jul 5;26(31):4596-9.
  • Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer.PLoS Med. 2007 Mar 20;4(3):e103.
  • Mucci LA, Wood PA, Cohen B, Clements KM, Brawarsky P, Brooks DR.Validity of self-reported health plan information in a population-based health survey.J Public Health Manag Pract. 2006 Nov-Dec;12(6):570-7.
  • Mucci LA, Adami HO.The role of epidemiology in understanding the relationship between dietary acrylamide and cancer risk in humans.Adv Exp Med Biol. 2005;561:39-47. Review.
  • Trolle-Lagerros Y, Mucci LA, Kumle M, Braaten T, Weiderpass E, Hsieh CC, Sandin S, Lagiou P, Trichopoulos D, Lund E, Adami HO.Physical activity as a determinant of mortality in women.Epidemiology. 2005 Nov;16(6):780-5.
  • Mucci LA, Adami HO, Wolk A.Prospective study of dietary acrylamide and risk of colorectal cancer among women.Int J Cancer. 2006 Jan 1;118(1):169-73.
  • Rubin MA, Bismar TA, Andrn O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE.Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1424-32.
  • Mucci LA, Sandin S, Blter K, Adami HO, Magnusson C, Weiderpass E.Acrylamide intake and breast cancer risk in Swedish women.JAMA. 2005 Mar 16;293(11):1326-7.
  • Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, Trichopoulos D.Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system?.BJU Int. 2001 Jun;87(9):814-20.